dacarbazine has been researched along with Nervous System Disorders in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (20.00) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Molczyk, A; Łata, S | 1 |
| Bock, HC; Buchalla, R; Giese, A; Kantelhardt, SR; Ketter, R; Koll, S; Lohmann, F; Puchner, MJ; Rainov, N; Rohde, V; Schütze, M | 1 |
| Mateus, C; Robert, C | 1 |
| Boro, J; Cheung, MC; Ezzat, HM; Harris, M; Hicks, LK; Leitch, HA; Lima, VD; Montaner, JS | 1 |
| Lu, JQ; Mehta, V; Patel, S; Pugh, J; Wilson, BA | 1 |
| Dello Russo, C; Graziani, G; Navarra, P; Tentori, L; Tringali, G; Vairano, M | 1 |
| Iwamoto, T | 1 |
| Asher, AL; Chang, SM; Croteau, D; Grahn, AY; Husain, SR; Kunwar, S; Lang, FF; Parker, K; Puri, RK; Sampson, JH; Shaffrey, M; Sherman, JW; Vogelbaum, MA | 1 |
| Lefebvre, PJ; Luyckx, AS | 1 |
| Maurach, R; Strian, F | 2 |
| Aviles, A; Delgado, S | 1 |
| Feun, LG; Hurley, J; Marini, A; Savaraj, N | 1 |
| Davis, C; DeRosa, W; Durivage, HJ; Makuch, R; Murren, JR; Portlock, CS | 1 |
| Falkson, CI; Falkson, G; Falkson, HC | 1 |
4 review(s) available for dacarbazine and Nervous System Disorders
| Article | Year |
|---|---|
[Anti-CTLA-4 monoclonal antibody: a major step in the treatment of metastatic melanoma].
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, Neoplasm; Antineoplastic Agents, Alkylating; Autoimmune Diseases; Cancer Vaccines; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Combined Modality Therapy; CTLA-4 Antigen; Dacarbazine; Digestive System Diseases; Drug Screening Assays, Antitumor; Humans; Immunotherapy; Immunotherapy, Active; Ipilimumab; Melanoma; Melanoma, Experimental; Mice; Monitoring, Immunologic; Nervous System Diseases; Vaccines, Subunit | 2011 |
[Pharmacokinetic and molecular biological approaches to achieve the safety and effective management of drug therapies].
Topics: Anti-Bacterial Agents; Biomarkers; Blood Glucose; Dacarbazine; Diabetes Mellitus; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Humans; Medication Errors; Nervous System Diseases; Pharmacokinetics; Prednisolone; Risk Factors; Safety Management; Vancomycin | 2007 |
[The glucagonomas (author's transl)].
Topics: Adenoma, Islet Cell; Adult; Aged; Amino Acids; Anemia; Arginine; Body Weight; Cholesterol; Dacarbazine; Diabetes Mellitus; Diagnosis, Differential; Erythema; Female; Glossitis; Glucagon; Glucagonoma; Humans; Hypoproteinemia; Male; Middle Aged; Nervous System Diseases; Pancreatic Neoplasms; Somatostatin; Streptozocin; Thrombophlebitis; Zinc | 1981 |
[Cytostatic therapy: neurologic and psychiatric syndromes].
Topics: Antineoplastic Agents; Asparaginase; Cyclophosphamide; Cytarabine; Dacarbazine; Dactinomycin; Doxorubicin; Fluorouracil; Humans; Methotrexate; Nervous System Diseases; Nitrosourea Compounds; Procarbazine; Psychoses, Substance-Induced; Vincristine | 1980 |
5 trial(s) available for dacarbazine and Nervous System Disorders
| Article | Year |
|---|---|
Convection-enhanced delivery of cintredekin besudotox (interleukin-13-PE38QQR) followed by radiation therapy with and without temozolomide in newly diagnosed malignant gliomas: phase 1 study of final safety results.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Dacarbazine; Dose-Response Relationship, Drug; Drug Delivery Systems; Exotoxins; Female; Glioma; Humans; Infusions, Intralesional; Interleukin-13; Male; Middle Aged; Nervous System Diseases; Radiotherapy, Conformal; Recombinant Fusion Proteins; Temozolomide; Treatment Outcome | 2007 |
A prospective clinical trial comparing chemotherapy, radiotherapy and combined therapy in the treatment of early stage Hodgkin's disease with bulky disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Follow-Up Studies; Gastrointestinal Diseases; Hematologic Diseases; Hodgkin Disease; Humans; Leukemia, Radiation-Induced; Life Tables; Lymphoma; Neoplasms, Second Primary; Nervous System Diseases; Prospective Studies; Pulmonary Fibrosis; Radiation Injuries; Radiotherapy, High-Energy; Remission Induction; Survival Analysis; Treatment Outcome; Vinblastine | 1998 |
Phase II trial of Paclitaxel and Dacarbazine with filgrastim administration in advanced malignant melanoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Female; Humans; Infusions, Intravenous; Male; Melanoma; Middle Aged; Nervous System Diseases; Paclitaxel; Skin Neoplasms; Treatment Outcome | 2002 |
High-dose cisplatin plus dacarbazine in the treatment of metastatic melanoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Drug Evaluation; Female; Hematologic Diseases; Humans; Kidney Diseases; Male; Melanoma; Middle Aged; Nervous System Diseases; Remission Induction; Survival Rate | 1991 |
Improved results with the addition of interferon alfa-2b to dacarbazine in the treatment of patients with metastatic malignant melanoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Female; Humans; Interferon alpha-2; Interferon-alpha; Life Tables; Male; Melanoma; Middle Aged; Nervous System Diseases; Recombinant Proteins; Survival Rate | 1991 |
6 other study(ies) available for dacarbazine and Nervous System Disorders
| Article | Year |
|---|---|
[Side effects of temozolomide treatment in patient with glioblastoma multiforme--case study].
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemotherapy, Adjuvant; Dacarbazine; Female; Glioblastoma; Humans; Middle Aged; Nervous System Diseases; Pancytopenia; Radiotherapy, Adjuvant; Temozolomide | 2010 |
First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Carmustine; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Drug Implants; Female; Glioblastoma; Humans; Karnofsky Performance Status; Male; Middle Aged; Nervous System Diseases; Risk Factors; Survival Analysis; Temozolomide; Treatment Outcome | 2010 |
Incidence, predictors and significance of severe toxicity in patients with human immunodeficiency virus-associated Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Bleomycin; Dacarbazine; Doxorubicin; Female; Hematologic Diseases; HIV Infections; HIV Protease Inhibitors; Hodgkin Disease; Humans; Incidence; Kaplan-Meier Estimate; Lopinavir; Lung Diseases; Male; Mechlorethamine; Middle Aged; Nervous System Diseases; Prednisone; Procarbazine; Prognosis; Retrospective Studies; Ritonavir; Vinblastine; Vincristine | 2012 |
Malignant glioma with angiocentric features.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Glioma; Humans; Magnetic Resonance Imaging; Male; Necrosis; Neoplasm Recurrence, Local; Nervous System Diseases; Temozolomide | 2013 |
Primary cultures of microglial cells for testing toxicity of anticancer drugs.
Topics: Animals; Animals, Newborn; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Cell Culture Techniques; Cell Survival; Dacarbazine; Drug Screening Assays, Antitumor; Humans; Lipopolysaccharides; Methotrexate; Microglia; Nervous System Diseases; Rats; Rats, Wistar; Temozolomide; Toxicity Tests | 2004 |
[Neurotoxic side effects of cytostatic therapy (author's transl)].
Topics: Antineoplastic Agents; Asparaginase; Cyclophosphamide; Cytarabine; Dacarbazine; Dactinomycin; Doxorubicin; Fluorouracil; Humans; Meningitis; Methotrexate; Nervous System Diseases; Nitrosourea Compounds; Procarbazine; Vincristine | 1981 |